🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalItaly AIFA reimbursement — anyone have experience? Page 8

Italy AIFA reimbursement — anyone have experience?

pete_nash Fri, Jul 11, 2025 at 10:03 PM 50 replies 2,366 viewsPage 8 of 10
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Oct 28, 2025 at 12:31 PM#36
bri_stats said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

15 15hyun_seoul, jim_asheville, matt_MKE and 12 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Nov 3, 2025 at 1:06 PM#37

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Nov 3, 2025 at 4:06 PM
14 14hank_denver, carlos_SATX, sophie_paris and 11 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Nov 9, 2025 at 1:44 PM#38
SleepDoc_PDX said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

13 13TomTeleRx, DoseLogDan, SleepFixSam and 10 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Nov 15, 2025 at 2:26 PM#39
SleepDoc_PDX said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Last edited: Nov 15, 2025 at 4:26 PM
12 12BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 9 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Nov 21, 2025 at 3:11 PM#40

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

40 15Dr.DermMIA, fiona_VT, denise_HTX and 37 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register